Navigation Links
Keystone Symposia to hold conference in Seattle on immunological mechanisms of vaccination
Date:8/24/2010

SILVERTHORNE, CO, August 24, 2010 Keystone Symposia on Molecular and Cellular Biology will convene its conference on "Immunological Mechanisms of Vaccination" in Seattle, Washington from October 27 to November 1, 2010 at Sheraton Seattle Hotel. This is the first conference of Keystone Symposia's 40th meeting season and its first in Seattle. It will be held at the conclusion of the Grand Challenges in Global Health conference, also taking place in Seattle for that program's grant recipients earlier in the week.

Part of the Keystone Symposia Global Health Series, supported by the Bill & Melinda Gates Foundation, the meeting will begin with keynote addresses on the evening of October 27, 2010 by Anthony S. Fauci of NIH and Tadataka Yamada of Bill & Melinda Gates Foundation, as well as a joint reception with the Grand Challenges in Global Health conference attendees.

Additional speakers over the course of the following four days will include Rafi Ahmed of Emory University School of Medicine, Norman Baylor of the US FDA, Robert L. Coffman of Dynavax Technologies, Stefan H.E. Kaufmann of Max Planck Institute for Infection Biology, Lalita Ramakrishnan of the University of Washington and many others. Concluding remarks on the evening of October 31 will be delivered by Peter C. Doherty of the University of Melbourne, one of two 1996 winners of the Nobel Prize in Medicine or Physiology for discovering how white blood cells recognize and kill virus-infected cells.

The four-day conference will bring together more than 400 researchers from around the world confronting a range of different diseases that would benefit from vaccine development. Included among the attendees will be 58 researchers and students originating from 27 developing countries who have received Keystone Symposia Global Health Travel Awards to attend the conference.

The goal of the meeting is to bring together, and encourage crosstalk between, vaccinologists, immunolo
'/>"/>

Contact: Yvonne Psaila
yvonnep@keystonesymposia.org
970-262-2676
Keystone Symposia on Molecular & Cellular Biology
Source:Eurekalert

Page: 1 2

Related biology news :

1. Keystone Symposia awarded $1.37 million, 5-year NIH grant to fund ongoing diversity efforts
2. Keystone Symposia appoints 5 Fellows as part of diversity in life science initiative
3. Satellite symposia enhance scientific program with quality information and practical new knowledge
4. Symposia selected for Entomological Society of America meeting
5. BIO-key® Announces Second Quarter 2010 Earnings Release and Conference Call Schedule
6. Teleconference Alert: LyondellBasell Reviews Second Quarter 2010 Financial Results
7. University of Maryland co-sponsors International Conference on the Effects of Noise on Aquatic Life
8. AACR hosts cancer disparities conference in Miami, Fla.
9. BIO-key® International to Exhibit at Allscripts 2010 Client Experience Conference
10. AACR hosts molecular diagnostics conference in Denver, Colo.
11. Chances of hurricane hitting Texas discussed at UH conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... scientists unveiled the first high-resolution map of the ... country of Per. The new and improved methodology ... change for future market-based carbon economies. The ... ecological diversity and it provides the critical input ... conservation, land use, and enforcement purposes. The technique ...
(Date:7/29/2014)... of Bristol,s Nutrition and Behaviour Unit (NBU) has looked ... planning meals. , The research, to be presented at ... (SSIB 2014) in Seattle, USA this week [29 July ... team was led by Professor Jeff Brunstrom, and is ... part of a Biotechnology and Biological Sciences Research Council ...
(Date:7/29/2014)... the climate warms and sea ice retreats, the North ... of increasingly open water which is predicted to extend ... this century. Storms thus have the potential to create ... new and unpredictable element to the region. , A University ... in the middle of the Arctic Ocean, and detected ...
Breaking Biology News(10 mins):Peru's carbon quantified: Economic and conservation boon 2Peru's carbon quantified: Economic and conservation boon 3Huge waves measured for first time in Arctic Ocean 2Huge waves measured for first time in Arctic Ocean 3
... engineers at Purdue University have developed a new method ... and they are proposing the creation of mobile processing ... fuels. "What,s important is that you can ... chips, switch grass, corn stover, rice husks, wheat straw ...
... tract is a teeming mass of hundreds of types of ... help us digest food and keep bad bacteria in check. ... receptor is a key player amid the gut bacteria ... helping to govern their activity, responding to their cues, and ...
... calling on policymakers to encourage the transition from coal-based electricity ... carbon tax. Such a mechanism would help limit carbon ... Change Conference in Copenhagen last December, the United States pledged ... by 17 percent by 2020. Dagobert Brito, the ...
Cached Biology News:New biofuels processing method for mobile facilities 2New biofuels processing method for mobile facilities 3Amid the murk of 'gut flora,' vitamin D receptor emerges as a key player 2Amid the murk of 'gut flora,' vitamin D receptor emerges as a key player 3Researchers calculate the cost of CO2 emissions, call for carbon tax 2
(Date:7/30/2014)... Mass. , July 30, 2014  Decision ... pharmacy and medical directors in the ... drivers of biosimilar market penetration will be the ... organizations (MCOs) and the expected lower cost to ... for biosimilars that meet their pricing expectations in ...
(Date:7/30/2014)... 30, 2014 While administrative claims ... services research for a relatively long period of ... regarding the use of these ‘big data’ for ... By combining today’s powerful computer technology with the ... ‘big data’ holds significant promise for identifying optimal ...
(Date:7/30/2014)... July 30, 2014 With the ... of personal health expenditure as well as the ... system, China diagnostic reagent industry has been developing ... 90%. In 2013, Chinese in vitro diagnostics market ... came from in vitro diagnostic reagents. , ...
(Date:7/30/2014)... (PRWEB) July 30, 2014 Yuma ... facility and complementary therapies brings comprehensive cancer care ... state-of-the-art Yuma Regional Cancer Center has officially opened. ... the program includes services such as open, semi-private ... therapy, American Cancer Society Resource Center, hematology, rehabilitation ...
Breaking Biology Technology:Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 2Surveyed U.S. Payers Expect Cost Savings to MCOs and Patients to be the Strongest Drivers of Biosimilar Uptake 3Leveraging ‘Big Data’ - Methodological Considerations in Health Services Research, New Webinar Hosted by Xtalks 2China Diagnostic Reagent Industry Report, 2013-2016 | Researchmoz 2China Diagnostic Reagent Industry Report, 2013-2016 | Researchmoz 3Sate-of-the-Art Yuma Regional Cancer Center Officially Opens 2
... Pasteuria Bioscience announced that it has received registration ... Pasteuria usgae . This is a critical step towards ... bacteria prevalent in soil that have long been recognized as ... , "We,re very pleased to receive this EPA registration," ...
... STOCKHOLM, June 8 Diamyd Medical reported today,that the company ... to include children with type 1 diabetes from 10 years,of ... vaccine Diamyd(R). , (Logo: http://www.newscom.com/cgi-bin/prnh/20080314/297194 ... conducting two parallel phase III studies, one in,Europe and one ...
... Through One Year , , HERZLIYA, Israel and SKILLMAN, ... U.S. Food and Drug Administration (FDA) approved a labeling supplement ... EVOLENCE(R), a collagen-based dermal filler for the correction of moderate ... , , To view the Multimedia News Release, go ...
Cached Biology Technology:Pasteuria Bioscience Receives EPA Registration for Nematode Control 2Diamyd(R) Phase III Study Approved for Younger Patients in the US 2Photos: FDA Approves 12-Month Labeling Update for EVOLENCE(R) Collagen-Based Facial Filler 2Photos: FDA Approves 12-Month Labeling Update for EVOLENCE(R) Collagen-Based Facial Filler 3Photos: FDA Approves 12-Month Labeling Update for EVOLENCE(R) Collagen-Based Facial Filler 4
... (1995) This volume provides excellent ... for the study of major HIV proteins ... ribonuclease H, integrase and protease. Expression of ... Tat and Rev assays; HIV/CD4 interactions; transient ...
Monkey IL-2 ELISPOT Kit with white/opague microtiter plates...
Tachykinin (H-2)...
Human GATA-2 Affinity Purified Polyclonal Ab...
Biology Products: